A novel therapeutic approach to psoriasis with combination calcipotriol ointment and very low-dose cyclosporine: Results of a multicenter placebo-controlled study

This publication has 16 references indexed in Scilit:

• Efficacy and safety of calcipotriol (MC 903) ointment in psoriasis vulgaris: A randomized, double-blind, right/left comparative, vehicle-controlled study
  Journal of the American Academy of Dermatology, 1992
• Comparative study of calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgaris
  Journal of the American Academy of Dermatology, 1992
• 1α, 25-Dihydroxyvitamin D₃ (calcitriol) ointment in psoriasis
  Journal of Dermatological Treatment, 1992
• Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris
  The Lancet, 1991
• Efficacy of low-dose cyclosporin A in psoriasis: results of dose-finding studies
  British Journal of Dermatology, 1990
• In vivo beneficial effects of cyclosporin A and 1,25-dihydroxyvitamin D3 on the induction of experimental autoimmune thyroiditis
  Clinical Immunology and Immunopathology, 1990
• Potentiation of immunosuppressive effects of cyclosporin A by 1α,25-dihydroxyvitamin D3
  Cellular Immunology, 1989
• 1,25‐Dihydroxyvitamin D₃ POtentiates the in vitro inhibitory effects of cyclosporin A on T cells from rheumatoid arthritis patients
  Arthritis & Rheumatism, 1989
• A novel approach for the evaluation and treatment of psoriasis: Oral or topical use of 1,25-dihydroxyvitamin D3 can be a safe and effective therapy for psoriasis
  Journal of the American Academy of Dermatology, 1988
• Reproducibility of Clinical Trials of Topical Glucocorticosteroids
  International Journal of Dermatology, 1983